A combined oral contraceptive containing drospirenone…
A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial https://pubmed.ncbi.nlm.nih.gov/22465116/ Abstract Background: Combined oral contraceptives (COCs) may lead to a rise in cardiovascular disease risk, possibly associated with changes in blood pressure and endothelial function. Study design: The objective was to evaluate the impact of…